Website Thiswebinarwilladdressapproachestodevelopingandunderstandingthemanufacturingprocessforadrugsubstance | Edit Freely
Category This webinar will address approaches to developing and understanding the manufacturing process for a drug substance. The information obtained will enable completion of the drug substance information in Module 3 of a CTD application. Why should you Attend: This presentation is presented in practical language understandable by all technically educated or trained individuals, regardless of specialty. Areas Covered in the Session: Manufacturing process development Process controls Selection of starting materials Control strategy Process validation evaluation Submission of information Life cycle management Who Will Benefit: Quality Assurance Quality Control (Chem and Micro) Process and Design Engineering Process Automation Manufacturing Operations Validation Utility Operations Speaker Profile: Peggy J. Berry , MBA, RAC, is the President & CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development. She also provides group and one-on-one training in drug development, regulatory affairs and project management topics. Contact Detail: Compliance4All DBA NetZealous, Phone: +1-800-447-9407 Email: support@compliance4All.com
Deadline: June 21, 2017 | Date: June 22, 2017
Venue/Country: Online, U.S.A
Updated: 2017-04-24 18:49:40 (GMT+9)
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.